The Initiation of Vesicant Skin Injury at a Single Cell Level

单细胞水平上起泡性皮肤损伤

基本信息

  • 批准号:
    10708030
  • 负责人:
  • 金额:
    $ 23.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-21 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Abstract Sulfur mustard (mustard gas) and arsenicals such as lewisite are major threats as chemical warfare or terrorist agents. Despite different chemical structures, both types of agents lead to similar skin damage with large blisters and wounds that heal slowly, raising the specter of shared pathogenic mechanisms. In this proposal, we will investigate the role of oxidant skin injury as a shared mechanism in mustard and arsenical vesicant injury, employing nitrogen mustard and phenylarsine oxide as surrogates for sulfur mustard and lewisite, respectively. Although major advances have been made in vesicant research, we still do not have effective counter agents. This may be in part due to lack of full understanding of the pathogenesis of vesicants. The overarching hypothesis of this proposal is that defining the early effects of vesicants in vivo at subcellular and single cell levels will refine our understanding of the role of oxidative stress in vesicant skin injury and lead to new therapeutic strategies. We will also test the hypothesis that cobinamide, a highly effective and versatile antioxidant that neutralizes both reactive oxygen and nitrogen species, will be effective as a counter-agent and as means to understand better the role of oxidative stress in nitrogen mustard- and phenylarsine oxide-induced vesicant injury. The specific aims are: 1) To understand the initiation of nitrogen mustard- and phenylarsine oxide-induced skin injury at a single cell level. We will use in vivo fluorescence lifetime imaging (FLIM) and single cell RNA sequencing to gain a new view on the initiation of vesicant injury and the role of oxidative stress in the pathogenesis. 2) To define the efficacy of cobinamide against nitrogen mustard- and phenylarsine oxide-induced vesicant skin injury. We will test the efficacy of cobinamide against nitrogen mustard- and phenylarsine oxide-induced vesicant skin injury in mice. Due to differences between mouse and human skin, we will also investigate vesicant mechanisms in transplanted human skin. These studies are significant and innovative because they use state of the art tools to investigate a gap in our knowledge about the role of oxidative stress in the initiation of mustard and arsenical vesicant injury and because they test for the first time cobinamide, a highly effective antioxidant that is bifunctional for reactive oxygen and nitrogen species.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bogi Andersen其他文献

Bogi Andersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bogi Andersen', 18)}}的其他基金

Interdisciplinary Training Program in Skin Biology
皮肤生物学跨学科培训项目
  • 批准号:
    10612438
  • 财政年份:
    2022
  • 资助金额:
    $ 23.6万
  • 项目类别:
The Initiation of Vesicant Skin Injury at a Single Cell Level
单细胞水平上起泡性皮肤损伤
  • 批准号:
    10511732
  • 财政年份:
    2022
  • 资助金额:
    $ 23.6万
  • 项目类别:
Interdisciplinary Training Program in Skin Biology
皮肤生物学跨学科培训项目
  • 批准号:
    10410209
  • 财政年份:
    2022
  • 资助金额:
    $ 23.6万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10618812
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:
Skin Biology Resource-Based Center at UCI
UCI 皮肤生物学资源中心
  • 批准号:
    9903217
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:
Skin Biology Resource-Based Center at UCI
UCI 皮肤生物学资源中心
  • 批准号:
    10618811
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10199934
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:
Skin Biology Resource-Based Center at UCI
UCI 皮肤生物学资源中心
  • 批准号:
    10385794
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:
Skin Biology Resource-Based Center at UCI
UCI 皮肤生物学资源中心
  • 批准号:
    10199932
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10385795
  • 财政年份:
    2019
  • 资助金额:
    $ 23.6万
  • 项目类别:

相似海外基金

抗酸化能を高めたN-acetylcysteineによる老視と白内障抑制機構の解明
阐明具有增强抗氧化能力的N-乙酰半胱氨酸抑制老花眼和白内障的机制
  • 批准号:
    23K15945
  • 财政年份:
    2023
  • 资助金额:
    $ 23.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10758985
  • 财政年份:
    2023
  • 资助金额:
    $ 23.6万
  • 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10619173
  • 财政年份:
    2022
  • 资助金额:
    $ 23.6万
  • 项目类别:
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10517287
  • 财政年份:
    2021
  • 资助金额:
    $ 23.6万
  • 项目类别:
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
N-乙酰半胱氨酸治疗酒精使用障碍的随机对照试验
  • 批准号:
    nhmrc : 2001375
  • 财政年份:
    2021
  • 资助金额:
    $ 23.6万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10368472
  • 财政年份:
    2021
  • 资助金额:
    $ 23.6万
  • 项目类别:
N-acetylcysteineの骨治癒促進効果の検討
N-乙酰半胱氨酸促进骨愈合作用的考察
  • 批准号:
    20H01118
  • 财政年份:
    2020
  • 资助金额:
    $ 23.6万
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10221760
  • 财政年份:
    2020
  • 资助金额:
    $ 23.6万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10188441
  • 财政年份:
    2020
  • 资助金额:
    $ 23.6万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10462621
  • 财政年份:
    2020
  • 资助金额:
    $ 23.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了